[Role of lipid disorders in pathogenesis of diabetic microangiopathy].
Miyazawa-Hoshimoto
Saori
S
Department of Clinical Cell Biology, Graduate School of Medicine, Chiba University.
Takahashi
Kazuo
K
Saito
Yasushi
Y
D003925:Diabetic Angiopathies / Q000209:etiology* / Q000517:prevention & control; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006949:Hyperlipidemias / Q000188:drug therapy / Q000209:etiology*; D008077:Lipoproteins, LDL; D042461:Vascular Endothelial Growth Factor A
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008077:Lipoproteins, LDL; D042461:Vascular Endothelial Growth Factor A; C099252:oxidized low density lipoprotein